(Q44553038)

4 December 2017

Frequency and significance of antibodies to chromatin in autoimmune hepatitis (English)

1 reference

4 December 2017

1 reference

Albert J Czaja

1

1 reference

4 December 2017

Zakera Shums

2

1 reference

4 December 2017

Walter L Binder

3

1 reference

4 December 2017

Stephen J Lewis

4

1 reference

4 December 2017

Vicki J Nelson

5

1 reference

4 December 2017

Gary L Norman

6

1 reference

4 December 2017

language of work or name

1 reference

1 August 2003

1 reference

Digestive Diseases and Sciences

4 December 2017

1 reference

4 December 2017

48

1 reference

4 December 2017

8

1 reference

4 December 2017

1658-1664

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1024748714580

4 December 2017

0 references

cites work

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

1 reference

12 December 2020

A gender gap in autoimmunity.

1 reference

12 December 2020

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

12 December 2020

Behavior and significance of autoantibodies in type 1 autoimmune hepatitis

1 reference

12 December 2020

Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.

1 reference

12 December 2020

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

12 December 2020

Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine

1 reference

12 December 2020

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

1 reference

12 December 2020

Lupus, DNase and defective disposal of cellular debris

1 reference

12 December 2020

Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.

1 reference

12 December 2020

Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus

1 reference

12 December 2020

Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis

1 reference

12 December 2020

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

12 December 2020

The role of nucleosomes in lupus

1 reference

12 December 2020

Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis

1 reference

12 December 2020

Autoantibodies in liver disease

1 reference

12 December 2020

The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus

1 reference

12 December 2020

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

1 reference

12 December 2020

Autoantibodies: diagnostic fingerprints and etiologic perplexities.

1 reference

12 December 2020

Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis

1 reference

12 December 2020

Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis

1 reference

12 December 2020

Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: Correlation of serum transaminase and gamma globulin levels with histologic features

1 reference

12 December 2020

How lupoid is lupoid hepatitis?

1 reference

12 December 2020

Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association.

1 reference

12 December 2020

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

1 reference

12 December 2020

Genetic bases of autoimmune hepatitis.

1 reference

12 December 2020

Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis.

1 reference

12 December 2020

Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis

1 reference

12 December 2020

Histones: genetic diversity and tissue-specific gene expression

1 reference

12 December 2020

Diagnosis and treatment of autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of antibodies to histones in autoimmune hepatitis.

1 reference

12 December 2020

Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis

1 reference

12 December 2020

Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria

1 reference

12 December 2020

Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis

1 reference

12 December 2020

Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis

1 reference

12 December 2020

Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis

1 reference

12 December 2020

Shared genetic risk factors in autoimmune liver disease

1 reference

12 December 2020

Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I

1 reference

12 December 2020

High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.

1 reference

12 December 2020

Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs

1 reference

12 December 2020

Drug therapy in the management of type 1 autoimmune hepatitis

1 reference

12 December 2020

Understanding the pathogenesis of autoimmune hepatitis

1 reference

12 December 2020

Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1024748714580

1 reference

Dimensions Publication ID

4 December 2017

0 references

1 reference